Nanobiotix
- Country
- 🇫🇷France
- Ownership
- -
- Employees
- 102
- Market Cap
- -
- Introduction
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
NBTXR3 With or Without Cetuximab in LA-HNSCC
- Conditions
- Interventions
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 500
- Registration Number
- NCT04892173
- Locations
- 🇺🇸
Memorial Radiation Oncology Medical Group - Laguna Hills, Long Beach, California, United States
🇺🇸Hoag Hospital Newport Beach, Newport Beach, California, United States
🇺🇸CHRISTUS - St. Vincent Regional Cancer Center, Santa Fe, New Mexico, United States
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
- Conditions
- Metastatic Triple-Negative Breast CarcinomaMetastasis From Malignant Tumor of Bladder (Disorder)ImmunotherapyRadiotherapySquamous Cell Carcinoma of Head and NeckMetastatic Renal Cell CarcinomaMicrosatellite Instability-High Solid Malignant TumourMetastasis From Malignant Melanoma of Skin (Disorder)Metastasis From Malignant Tumor of LiverMetastasis From Malignant Tumor of Cervix
- Interventions
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 145
- Registration Number
- NCT03589339
- Locations
- 🇺🇸
Christus St. Vincent Regional Cancer Center, Santa Fe, New Mexico, United States
🇺🇸St Luke's University Health Network, Bethlehem, Pennsylvania, United States
🇺🇸Sanford Cancer Center, Sioux Falls, South Dakota, United States
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 5
- Registration Number
- NCT02805894
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
- First Posted Date
- 2016-03-28
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 23
- Registration Number
- NCT02721056
- Locations
- 🇫🇷
Centre René Gauducheau, Nantes, France
🇫🇷Institut de Cancérologie de Loraine, Nancy, France
🇫🇷Hôpital Haut-Lévêque, Pessac, France
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall
- Conditions
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 180
- Registration Number
- NCT02379845
- Locations
- 🇦🇺
Chris O'Brien Lifehouse, Sydney, Australia
🇦🇺Capital Region Cancer Service, Canberra Hospital, Canberra, Australia
🇧🇪Jules Bordet Institute, Bruxelles, Belgium
NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
- Conditions
- Interventions
- First Posted Date
- 2013-09-20
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 75
- Registration Number
- NCT01946867
- Locations
- 🇭🇺
Hungarian Defense Forces Hospital, Budapest, Hungary
🇪🇸Hospital Fundación Jimenez Diaz, Madrid, Spain
🇵🇱Centrum Onkologii - Instytut im. M. Skłodowskiej- Curie, Oddział w Gliwicach, Gliwice, Poland
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Nanobiotix
- Target Recruit Count
- 22
- Registration Number
- NCT01433068
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷Institut Gustave Roussy, Villejuif, France